Kanglaite injection

Clinical trial：

Kanglaite injection has synergistic effect on chemotherapy for  late stage non-small cell lung cancer , have certain resistance in patients with middle-late tumor cachexia and analgesic effect. Kanglaite soft capsule could relieve patients' pain and improve the quality of survival.

Deliver by air(Fedex/TNT/UPS). Please contact with us first and confirm the shipping method/fee and time.

What is KLT?

A: With its active ingredient extracted from seed of “semen coicis”, a natural anti-tumor herbal plant, Kanglaite Injection (KLT) is a novel dual-function, broad spectrum and molecular-targeting anti-neoplastic formulation for intravenous and intra-arterial application. KLT can directly inhibit and kill cells of various tumors, control lesions, and prevent metastasis. Simultaneously it is able to protect normal cells and improve immune function. In addition KLT presents significant role in relieving cancerous pain and cachexia and improving clinical symptoms so as to upgrade patient quality of life and prolong survival. KLT can be used alone or combined with chemotherapy or radiation therapy or applied peri-operationally. The combination therapy is able to remarkably enhance effect of chemotherapy or radiotherapy, prevent and minimize toxic side effect of these therapies and raise resection rate in operation. Therefore KLT is an ideal anticancer drug.

What are the major indications of KLT? 

A: Various stages primary lung cancer including NSCLC, primary hepatic cancer, pancreatic cancer and lymphoma. KLT has satisfactory therapeutic effect on various advanced tumors in palliative treatment in addition to its unique effect on cachexia and cancerous pain. 

 What is the active substance in KLT? 

A: It is coix triglyceride that is already patented in 11 countries and regions in the world.

How to Use

The usual dosage is 200ml/day by slow intravenous infusion. Once a day. One therapeutic lasts 21 days. After one course the patients should have a rest interval of 3-5 days before taking the next course. When combined with chemotherapy or radiotherapy, the dosage of Kanglaite injection could be reduced accordingly. At the beginning of IV instillation, the drip speed is advisable to be adjusted to 20 drops/min during the first 10 minutes, which can be continuously increased after 20 minutes and be controlled to 40-60 drops/min after 30 min.

Cautions

Not for use during pregnancy.

Shelf-life: 18 months

Executive standard: Chinese Pharmacopoeia 2010, volumeⅠ.

Manufacturer: Company name: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

The difference of Adjuvant therapy/cancer medicines